DE602005021889D1 - Substituierte thienopyrrolcarbonsäureamide, pyrrolothiazolcarbonsäureamide und verwandte analoga als inhibitoren von caseinkinase-i-epsilon - Google Patents

Substituierte thienopyrrolcarbonsäureamide, pyrrolothiazolcarbonsäureamide und verwandte analoga als inhibitoren von caseinkinase-i-epsilon

Info

Publication number
DE602005021889D1
DE602005021889D1 DE602005021889T DE602005021889T DE602005021889D1 DE 602005021889 D1 DE602005021889 D1 DE 602005021889D1 DE 602005021889 T DE602005021889 T DE 602005021889T DE 602005021889 T DE602005021889 T DE 602005021889T DE 602005021889 D1 DE602005021889 D1 DE 602005021889D1
Authority
DE
Germany
Prior art keywords
thienopyrrolcarbonsäureamide
pyrrolothiazolcarbonsäureamide
caseinkinase
analoga
substituierte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005021889T
Other languages
English (en)
Inventor
David Marc Fink
Yulin Chiang
Nicola Dawn Collar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of DE602005021889D1 publication Critical patent/DE602005021889D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
DE602005021889T 2004-08-19 2005-08-18 Substituierte thienopyrrolcarbonsäureamide, pyrrolothiazolcarbonsäureamide und verwandte analoga als inhibitoren von caseinkinase-i-epsilon Active DE602005021889D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60334704P 2004-08-19 2004-08-19
PCT/US2005/029383 WO2006021000A2 (en) 2004-08-19 2005-08-18 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon

Publications (1)

Publication Number Publication Date
DE602005021889D1 true DE602005021889D1 (en) 2010-07-29

Family

ID=35695546

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005021889T Active DE602005021889D1 (en) 2004-08-19 2005-08-18 Substituierte thienopyrrolcarbonsäureamide, pyrrolothiazolcarbonsäureamide und verwandte analoga als inhibitoren von caseinkinase-i-epsilon

Country Status (31)

Country Link
US (2) US7393867B2 (de)
EP (1) EP1784409B1 (de)
JP (1) JP4869232B2 (de)
KR (1) KR20070045263A (de)
CN (1) CN100562521C (de)
AR (1) AR051008A1 (de)
AT (1) ATE471326T1 (de)
AU (1) AU2005272584B2 (de)
BR (1) BRPI0514419A (de)
CA (1) CA2577879C (de)
CY (1) CY1110775T1 (de)
DE (1) DE602005021889D1 (de)
DK (1) DK1784409T3 (de)
ES (1) ES2347166T3 (de)
GT (1) GT200500215A (de)
HK (1) HK1105198A1 (de)
HR (1) HRP20100475T1 (de)
IL (1) IL181158A0 (de)
JO (1) JO2629B1 (de)
MY (1) MY139831A (de)
PA (1) PA8642801A1 (de)
PE (1) PE20060630A1 (de)
PL (1) PL1784409T3 (de)
PT (1) PT1784409E (de)
RS (1) RS51413B (de)
RU (1) RU2403257C2 (de)
SI (1) SI1784409T1 (de)
SV (1) SV2006002190A (de)
TW (1) TWI372149B (de)
UY (1) UY29077A1 (de)
WO (1) WO2006021000A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007517056A (ja) 2003-12-29 2007-06-28 セプラコア インコーポレーテッド ピロール及びピラゾールdaao阻害剤
JP5438975B2 (ja) 2006-01-06 2014-03-12 サノビオン ファーマシューティカルズ インク テトラロン系モノアミン再取り込み阻害剤
RU2430913C2 (ru) 2006-01-06 2011-10-10 Сепракор Инк. Циклоалкиламины в качестве ингибиторов повторного поглощения моноамина
DK2013835T3 (en) 2006-03-31 2015-12-14 Sunovion Pharmaceuticals Inc Preparation of chiral amides and AMINES
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
EP1955699A1 (de) * 2007-02-08 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Verwendung von Flibanserin zur Behandlung von Schlaflosigkeit
MX2009012685A (es) 2007-05-31 2009-12-14 Sepracor Inc Cicloalquilaminas sustituidas con fenilo como inhibidores de la reabsorcion de monoamina.
US9018238B2 (en) 2009-02-12 2015-04-28 Pharmadesign, Inc. Inhibitor of casein kinase 1δ and casein kinase 1ε
CN102459283B (zh) * 2009-05-28 2014-11-12 沃泰克斯药物股份有限公司 C-met 蛋白激酶的氨基吡唑三唑并噻二唑抑制剂
ES2460065T3 (es) * 2009-10-28 2014-05-13 Pfizer Inc. Derivados de imidazol como inhibidores de la caseína quinasa
DE102009058280A1 (de) * 2009-12-14 2011-06-16 Merck Patent Gmbh Thiazolderivate
WO2012020726A1 (ja) 2010-08-09 2012-02-16 株式会社ファルマデザイン カゼインキナーゼ1δ及びカゼインキナーゼ1ε阻害剤
CN109748927A (zh) * 2017-11-03 2019-05-14 上海交通大学医学院附属瑞金医院 杂芳基酰胺类化合物、其制备方法、药用组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100722176B1 (ko) * 1999-06-08 2007-05-29 아벤티스 파마슈티칼스 인크. 일주기 리듬 단백질을 변화시키기 위한 스크리닝 방법
US7402672B2 (en) * 2003-12-11 2008-07-22 Aventis Pharmaceuticals Inc. Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon

Also Published As

Publication number Publication date
TW200621788A (en) 2006-07-01
EP1784409B1 (de) 2010-06-16
PL1784409T3 (pl) 2010-10-29
PA8642801A1 (es) 2006-05-16
US20070299112A1 (en) 2007-12-27
AU2005272584A1 (en) 2006-02-23
US20080227822A1 (en) 2008-09-18
PE20060630A1 (es) 2006-08-03
JP2008510712A (ja) 2008-04-10
BRPI0514419A (pt) 2008-06-10
SV2006002190A (es) 2006-05-24
RU2403257C2 (ru) 2010-11-10
EP1784409A2 (de) 2007-05-16
HK1105198A1 (en) 2008-02-06
JP4869232B2 (ja) 2012-02-08
RU2007109812A (ru) 2008-09-27
WO2006021000A2 (en) 2006-02-23
GT200500215A (es) 2006-03-27
CY1110775T1 (el) 2015-06-10
SI1784409T1 (sl) 2010-10-29
PT1784409E (pt) 2010-09-06
WO2006021000A3 (en) 2006-06-15
AR051008A1 (es) 2006-12-13
TWI372149B (en) 2012-09-11
MY139831A (en) 2009-10-30
US7393867B2 (en) 2008-07-01
RS51413B (en) 2011-02-28
US7652046B2 (en) 2010-01-26
KR20070045263A (ko) 2007-05-02
IL181158A0 (en) 2007-07-04
ES2347166T3 (es) 2010-10-26
ATE471326T1 (de) 2010-07-15
JO2629B1 (en) 2012-06-24
HRP20100475T1 (hr) 2010-10-31
CN101001861A (zh) 2007-07-18
CA2577879C (en) 2011-07-12
CA2577879A1 (en) 2006-02-23
DK1784409T3 (da) 2010-09-27
CN100562521C (zh) 2009-11-25
AU2005272584B2 (en) 2010-11-11
UY29077A1 (es) 2006-03-31

Similar Documents

Publication Publication Date Title
DE602005021889D1 (en) Substituierte thienopyrrolcarbonsäureamide, pyrrolothiazolcarbonsäureamide und verwandte analoga als inhibitoren von caseinkinase-i-epsilon
AP2204A (en) 4-phenylamino-quinazolin-6-yl-amides.
DE602004031777D1 (en) Thiophenderivate als chk-1-inhibitoren
DE602005014383D1 (en) Thienopyridinderivate als allostere gaba-b-enhancer
EP1787458A4 (de) Maschinelles lernen
EP1779867A4 (de) Mittel zur förderung der nervenreveneration
HK1101856A1 (en) Pyrrolidine-3,4-dicarboxamide derivatives
AP2006003791A0 (en) 1-Heterocyclyl-1,5-dihydro-pyridoÄ3,2-BÜindol-2-ones
GB0421385D0 (en) Control units
GB0427796D0 (en) Machine control system
GB0423094D0 (en) Interrupt control
GB2418745B (en) I S machine
GB0425572D0 (en) 1,7-Naphthyridines
GB0521382D0 (en) Control for an I.S. machine
DE602005008581D1 (en) Trisubstituierte harnstoffe als cytokininhibitoren
AU302270S (en) Joystick control
GB0521381D0 (en) Control for an I.S. machine
DE502005010179D1 (en) Alkylcarbamat-substituierte butyrolactone als lipase-inhibitoren
PL379986A1 (pl) Panel, zwłaszcza panel podłogowy
GB2420725B (en) Pollution control
TWM350558U (en) Texturierduse zum texturieren von endlosgarn
GB0415061D0 (en) Control agents
HK1063985A2 (en) Semi-automatic finger escaper.
AU2004900643A0 (en) Novel piperidines as CGRP ligands
GB2411411B (en) Superstructure